サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1400994

樹状細胞がんワクチン市場：タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年

Dendritic Cell Cancer Vaccine Market, by Type and by End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 250 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
樹状細胞がんワクチン市場：タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年
出版日: 2023年12月17日
発行: AnalystView Market Insights
ページ情報: 英文 250 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

樹状細胞がんワクチンの市場規模は2022年に5億3,942万米ドルとなり、2023年から2030年にかけてCAGR 12.22%で拡大すると予想されます。

樹状細胞がんワクチン市場力学

がん患者数の増加が市場成長を促進

がんワクチン開発への政府支援の増加やワクチン接種技術の飛躍的進歩が市場拡大を促進しています。男性のがん患者は2040年までに15,585,096人に達すると予測され、女性のがん患者は2040年までに13,302,846人に達すると予測されます。世界人口の間でがん有病率が高まっていることが、市場拡大の原動力となりそうです。同様に、欧州がん情報システムは、2020年の非黒色腫皮膚がんの予測発生率は2,681,958人であり、2040年までに3,244,076人に増加すると予測されると2020年に報告しました。様々な国でがんの有病率が上昇していることから、がんワクチンの需要が高まり、今後数年間の市場拡大が見込まれます。

樹状細胞がんワクチン市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、樹状細胞がんワクチンの世界市場は、予測期間（2023-2030年）に約12.22％のCAGRで毎年成長すると予測されています。

樹状細胞がんワクチン市場は、市場成長を促進するがん患者数の増加により、著しい速度で成長すると予測されています。

市場セグメンテーションに基づくと、2022年にはSipuleucel-T（Provenge）が最大の市場シェアを示すと予測されます。

エンドユーザー別では、成人が2022年の主要エンドユーザーです。

地域別では、北米が2022年の収益でリードしています。

樹状細胞がんワクチン市場-セグメンテーション分析：

世界の樹状細胞がんワクチン市場は、タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプ別に分類される：creaVax、Sipuleucel-T（Provenge）、その他。Sipuleucel-Tは腫瘍細胞に対する個人の免疫力を高める可能性があり、市場の需要を高めています。このワクチンは2010年に米国食品医薬品局から去勢抵抗性前立腺がんの治療薬として認可されました。多くの研究により、Sipuleucel-Tの使用は免疫力を高め、副作用が少なく、生存者の寿命を延ばすことが判明しています。

市場はエンドユーザー別に小児用と成人用に分けられます。2022年には世界中でがん患者が増加するため、成人向け予防接種市場のカテゴリーが最大の市場シェアを占めています。さらに、世界中の多くの研究者が、将来的な治療ソリューションを実現するための効率的なワクチン候補を生み出すための綿密な調査を行っています。

樹状細胞がんワクチン市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米地域は成長が見込まれています。2022年、樹状細胞がんワクチン市場は北米が支配的となります。この地域の樹状細胞がんワクチン市場の拡大には、がん患者の異常な増加や、大学の研究機関や製薬大手が支援する数多くの調査研究が大きく寄与しています。

樹状細胞がんワクチン市場-競合情勢：

企業は、企業ウェブサイト、eコマースウェブサイト、小売業者、流通業者、最終消費者など、さまざまなチャネルを通じて製品を販売しています。製品メーカーは、製品のコスト、性能、製品作り、技術、評判、入手可能性など、さまざまな側面で競争しています。リーチを強化し市場シェアを拡大するために企業が用いる主なタイプには、新製品の発売、流通網の開拓、研究開発費、M&Aなどがあります。

目次

第1章 樹状細胞がんワクチン市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 樹状細胞がんワクチンの主要市場動向

  • 樹状細胞がんワクチン市場促進要因
  • 樹状細胞がんワクチン市場抑制要因
  • 樹状細胞がんワクチン市場機会
  • 樹状細胞がんワクチン市場の今後の動向

第4章 樹状細胞がんワクチン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 樹状細胞がんワクチン市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 樹状細胞がんワクチン市場情勢

  • 樹状細胞がんワクチン市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 樹状細胞がんワクチン市場：タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • CreaVax
    • Sipuleucel-T（Provenge）
    • その他

第8章 樹状細胞がんワクチン市場：エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 小児
    • 成人

第9章 樹状細胞がんワクチン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：樹状細胞がんワクチン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Vaximm AG
    • SOTIO
    • Scancell Holdings PLC
    • Northwest Biotherapeutics（Now known as Cognate BioServices）
    • NewLink Genetics（Now known as Lumos Pharma）
    • Medigene AG
    • Immunicum
    • Dendreon Pharmaceuticals LLC
    • DCPrime
    • DanDrit Biotech
    • CIMAB SA（Cuba）
    • Cellular Biomedicine Group
    • Bellicum Pharmaceuticals
    • Batavia Biosciences
    • Argos Therapeutics（Now part of Roivant Sciences）

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Dendritic Cell Cancer Vaccine Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Dendritic Cell Cancer Vaccine Market, by Type 2018-2030 (USD Million)
  • TABLE Dendritic Cell Cancer Vaccine Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Dendritic Cell Cancer Vaccine Market, by End-User 2018-2030 (USD Million)
  • TABLE Dendritic Cell Cancer Vaccine Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Dendritic Cell Cancer Vaccine Market, by Region 2018-2030 (USD Million)
  • TABLE North America Dendritic Cell Cancer Vaccine Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Dendritic Cell Cancer Vaccine Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Dendritic Cell Cancer Vaccine Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Dendritic Cell Cancer Vaccine Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Dendritic Cell Cancer Vaccine Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Dendritic Cell Cancer Vaccine Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dendritic Cell Cancer Vaccine Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dendritic Cell Cancer Vaccine Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Dendritic Cell Cancer Vaccine Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Dendritic Cell Cancer Vaccine Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Dendritic Cell Cancer Vaccine Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Dendritic Cell Cancer Vaccine Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dendritic Cell Cancer Vaccine Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dendritic Cell Cancer Vaccine Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Dendritic Cell Cancer Vaccine Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Dendritic Cell Cancer Vaccine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Dendritic Cell Cancer Vaccine Market share and leading players, 2022
  • FIGURE Europe Dendritic Cell Cancer Vaccine Market share and leading players, 2022
  • FIGURE Asia Pacific Dendritic Cell Cancer Vaccine Market share and leading players, 2022
  • FIGURE Latin America Dendritic Cell Cancer Vaccine Market share and leading players, 2022
  • FIGURE Middle East and Africa Dendritic Cell Cancer Vaccine Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Dendritic Cell Cancer Vaccine Market share analysis by country, 2022
  • FIGURE Germany Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Dendritic Cell Cancer Vaccine Market share analysis by country, 2022
  • FIGURE India Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Dendritic Cell Cancer Vaccine Market share analysis by country, 2022
  • FIGURE Brazil Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Dendritic Cell Cancer Vaccine Market share analysis by country, 2022
  • FIGURE Saudi Arabia Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Dendritic Cell Cancer Vaccine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1958

REPORT HIGHLIGHT

Dendritic Cell Cancer Vaccine market size was valued at USD 539.42 Million in 2022, expanding at a CAGR of 12.22% from 2023 to 2030.

A dendritic cell cancer vaccine is a treatment method in which dendritic cells, a kind of immune cell, are used to activate the patient's immune system to target and eliminate cancer cells. Dendritic cells are loaded with cancer-specific antigens from either the patient's own tumor or synthetic sources before being reintroduced into the patient's body. This process stimulates the immune system, making it more capable of recognizing and attacking cancer cells. Dendritic cell cancer vaccines are being researched as a possible immunotherapy to treat many forms of cancer and boost the body's natural defenses against the illness.

Dendritic Cell Cancer Vaccine Market Dynamics

The rise in the number of cancer patients to propel the market growth

Increased government support for the development of cancer vaccines, as well as breakthroughs in vaccination technology, are driving market expansion. Male cancer cases were anticipated to reach 15,585,096 by 2040, while female cancer cases were expected to reach 13,302,846 by 2040. The growing prevalence of cancer among the worldwide population is likely to fuel market expansion. Similarly, the European Cancer Information System reported in 2020 that the projected incidence of non-melanoma skin cancers in 2020 was 2,681,958 and was predicted to rise to 3,244,076 by 2040. The rising prevalence of cancer in various nations is likely to fuel demand for cancer vaccines, propelling market expansion over the next several years.

Dendritic Cell Cancer Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the Global Dendritic Cell Cancer Vaccine market is estimated to grow annually at a CAGR of around 12.22% over the forecast period (2023-2030)

The Dendritic Cell Cancer Vaccine market is projected to grow at a significant rate due to the rise in the number of cancer patients to propel the market growth

Based on Type segmentation, Sipuleucel-T (Provenge) was predicted to show maximum market share in the year 2022

Based on End-User segmentation, Adults were the leading End-User in 2022

On the basis of region, North America was the leading revenue generator in 2022

Dendritic Cell Cancer Vaccine Market- Segmentation Analysis:

The Global Dendritic Cell Cancer Vaccine market is segmented on the basis of Type, End-User, and Region.

The market is divided into categories based on Type: By creaVax, sipuleucel-T (Provenge), and others. Sipuleucel-T's potential to successfully boost an individual's immunity against tumor cells is increasing its market demand. The vaccine was licensed by the US Food and Drug Administration in 2010 for the treatment of castrate-resistant prostate cancer. Many studies have found that utilizing Sipuleucel-T increases immunity, has few negative effects, and increases a survivor's longevity.

The market is divided into categories based on End-User: Pediatrics and Adults. Due to the increasing number of cancer cases throughout the world in 2022, the adult vaccinations market category had the largest market share. Additionally, a large number of researchers throughout the world are doing in-depth studies to generate efficient vaccination candidates to realize prospective treatment solutions.

Dendritic Cell Cancer Vaccine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America region is expected to grow. In 2022, the market for dendritic cell cancer vaccines will be dominated by North America. An extraordinary increase in cancer cases and numerous research studies supported by university research institutes and pharmaceutical behemoths are mostly to blame for the region's dendritic cell cancer vaccine market expansion.

Dendritic Cell Cancer Vaccine Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary Types used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions.

Recent Developments:

In February 2022, Medigene and BioNTech have agreed to work together to develop T-cell immunotherapies that target several solid tumor sites. Through the partnership, Medigene's preclinical T-cell receptors (TCR) initiatives, which employ Medigene's switch-receptor technology for the creation of TCR treatments and dendritic cell vaccines, will be acquired by BioNTech.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DENDRITIC CELL CANCER VACCINE MARKET KEY PLAYERS

  • Vaximm AG
  • SOTIO
  • Scancell Holdings PLC
  • Northwest Biotherapeutics (Now known as Cognate BioServices)
  • NewLink Genetics (Now known as Lumos Pharma)
  • Medigene AG
  • Immunicum
  • Dendreon Pharmaceuticals LLC
  • DCPrime
  • DanDrit Biotech
  • CIMAB S.A. (Cuba)
  • Cellular Biomedicine Group
  • Bellicum Pharmaceuticals
  • Batavia Biosciences
  • Argos Therapeutics (Now part of Roivant Sciences)

GLOBAL DENDRITIC CELL CANCER VACCINE MARKET, BY TYPE

  • CreaVax
  • Sipuleucel-T (Provenge)
  • Others

GLOBAL DENDRITIC CELL CANCER VACCINE MARKET, BY END-USER

  • Pediatrics
  • Adults

GLOBAL DENDRITIC CELL CANCER VACCINE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Dendritic Cell Cancer Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Dendritic Cell Cancer Vaccine Market Snippet by Type
    • 2.1.2. Dendritic Cell Cancer Vaccine Market Snippet by End-User
    • 2.1.3. Dendritic Cell Cancer Vaccine Market Snippet by Country
    • 2.1.4. Dendritic Cell Cancer Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Semiconductor Memory Key Market Trends

  • 3.1. Dendritic Cell Cancer Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Dendritic Cell Cancer Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Dendritic Cell Cancer Vaccine Market Opportunities
  • 3.4. Dendritic Cell Cancer Vaccine Market Future Trends

4. Semiconductor Memory Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Dendritic Cell Cancer Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Dendritic Cell Cancer Vaccine Market Landscape

  • 6.1. Dendritic Cell Cancer Vaccine Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Dendritic Cell Cancer Vaccine Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. CreaVax
    • 7.1.3. Sipuleucel-T (Provenge)
    • 7.1.4. Others

8. Dendritic Cell Cancer Vaccine Market - By End-User

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 8.1.2. Pediatrics
    • 8.1.3. Adults

9. Dendritic Cell Cancer Vaccine Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Semiconductor Memory Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Semiconductor Memory Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Semiconductor Memory Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Semiconductor Memory Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Semiconductor Memory Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Semiconductor Memory Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Vaximm AG
    • 10.2.2. SOTIO
    • 10.2.3. Scancell Holdings PLC
    • 10.2.4. Northwest Biotherapeutics (Now known as Cognate BioServices)
    • 10.2.5. NewLink Genetics (Now known as Lumos Pharma)
    • 10.2.6. Medigene AG
    • 10.2.7. Immunicum
    • 10.2.8. Dendreon Pharmaceuticals LLC
    • 10.2.9. DCPrime
    • 10.2.10. DanDrit Biotech
    • 10.2.11. CIMAB S.A. (Cuba)
    • 10.2.12. Cellular Biomedicine Group
    • 10.2.13. Bellicum Pharmaceuticals
    • 10.2.14. Batavia Biosciences
    • 10.2.15. Argos Therapeutics (Now part of Roivant Sciences)

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us